← All organizations

Tocagen Inc.

For profitWebsite ↗

Also known as: Tocagen Inc.

Phase 1 Phase 2 Phase 3 Phase 4

Highest phase reached

Phase 3

First clinical trial

Last known activity

Dec 31, 2019

Defunct as of Feb 21, 2020

Timeline

2000s

Jun 1, 2007
Tocagen Inc.— Founded

2020s

Feb 21, 2020
Tocagen Inc.— Defunct

Drugs by trial phase (6 distinct, 8 trials)

Phase 3 (5 own, 0 via acquisition)

Phase 1 (1 own, 0 via acquisition)

Fluorocytosine

Indications

Studied for

Recent trials (9)

NCT04089163Lead sponsorPhase 1Dec 31, 2019
NCT02576665Lead sponsorPhase 1Jul 1, 2016
NCT02598011Lead sponsorPhase 1Mar 1, 2016
NCT02414165Lead sponsorPhase 2/Phase 3Nov 1, 2015
NCT01985256Lead sponsorPhase 1Oct 1, 2013
NCT01470794Lead sponsorPhase 1Jan 1, 2012
NCT04327011Lead sponsorPhase 1Feb 28, 2011
NCT04327011Study directorPhase 1Feb 28, 2011
NCT01156584Lead sponsorPhase 1Jun 1, 2010

Details

Founded: San Diego, CA, US Jun 1, 2007
Last known activity: Dec 31, 2019